Reach Us +44-7482-864460
Muzyczka N | OMICS International
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Muzyczka N

Nicholas Muzyczka Mcknight Brain Institute Gainesville USA


Dr. Nicholas Muzyczka, Ph.D., also known as Nick, Co-Founded Applied Genetic Technologies Corporation in 1999. As a fellow in Dan Nathans laboratory, Dr. Muzyczka designed some of the earliest mammalian vectors based on SV40 virus. He subsequently developed the first AAV vectors and has been a leader in the development of this vector technology. He has contributed both to the study of the basic biology of AAV, as well as its application to human diseases. His laboratory is currently the leader in studies of the biochemistry of AAV transcription, DNA replication, and packaging. He is also a leader in the use of AAV vectors for central nervous system therapy. Dr. Muzyczka served as a Director at Applied Genetic Technologies Corporation. Dr. Muzyczka received his B.S. in Biology at Antioch College and his Ph.D. in Biochemistry at Johns Hopkins University.

Research Interest

Moloecular biology, Genetics, Virology